R, H. (1997). Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain : a journal of neurology, 120 ( Pt 5), 865. https://doi.org/10.1093/brain/120.5.865
Chicago Style (17th ed.) CitationR, Hohlfeld. "Biotechnological Agents for the Immunotherapy of Multiple Sclerosis. Principles, Problems and Perspectives." Brain : A Journal of Neurology 120 ( Pt 5) (1997): 865. https://doi.org/10.1093/brain/120.5.865.
MLA (9th ed.) CitationR, Hohlfeld. "Biotechnological Agents for the Immunotherapy of Multiple Sclerosis. Principles, Problems and Perspectives." Brain : A Journal of Neurology, vol. 120 ( Pt 5), 1997, p. 865, https://doi.org/10.1093/brain/120.5.865.
Warning: These citations may not always be 100% accurate.